The Innovative Medicines Initiative has provisionally selected 8 projects for funding from its fast-track Call for proposals on coronavirus diagnostics and treatments. Of the eight projects, five focus on diagnostics and three on treatments. The diagnostics projects hope to develop devices that can be used anywhere (including a doctor’s surgery or patient’s home) and will deliver results fast (ranging from 14 to 40 minutes). While the treatment projects focus primarily on the current COVID-19 outbreak, they also include efforts to prepare for future coronavirus outbreaks. The projects form part of the European Commission’s wider response to the coronavirus outbreak.In total, IMI received 144 proposals in response to the Call, of which 120 met the basic eligibility criteria for IMI support.

IMI stands for Innovative Medicines Initiative and is an EU public-private partnership funding health research and innovation. 

Read more on https://www.imi.europa.eu/news-events/press-releases/imi-announces-covid-projects-boosts-funding-pot-eur-72-million